The role of arginine residues in interleukin 1 receptor binding.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Biochimica et Biophysica Acta

• Publication date

  1991-12-11

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0167-4838(91)90437-5PMID 1837236
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High-resolution three-dimensional structure of interleukin 1 beta in solution by three- and four-dimensional nuclear magnetic resonance spectroscopy.

  1992cited by this paper
• Identification of key residues in the amino-terminal third of human interleukin-1 alpha.

  1990cited by this paper
• Structure of interleukin 1 alpha at 2.7-A resolution.

  1990cited by this paper
• Measurement of biologically active interleukin-1 by a soluble receptor binding assay.

  1990cited by this paper
• A point mutation uncouples human interleukin-1 beta biological activity and receptor binding.

  1990cited by this paper
• Evidence for different interleukin 1 receptors in murine B- and T-cell lines.

  1989cited by this paper
• Crystal structure of recombinant human interleukin-1 beta at 2.0 A resolution.

  1989cited by this paper
• Crystallographic refinement of interleukin 1 beta at 2.0 A resolution.

  1989cited by this paper
• Two high-affinity interleukin 1 receptors represent separate gene products.

  1989cited by this paper
• Crystal structure of recombinant human interleukin-1β at 2·0 Å resolution

  1989cited by this paper
• Role of interleukin 1 in the activation of T lymphocytes.

  1988cited by this paper
• DNA binding domain of Escherichia coli DNA polymerase I: identification of arginine-841 as an essential residue.

  1988cited by this paper
• Crystal structure of the cytokine interleukin‐1 beta.

  1988cited by this paper
• Site-specific mutagenesis of the human interleukin-1 beta gene: the role of arginine residue at the N-terminal region.

  1988cited by this paper
• Effects of murine recombinant interleukin 1 alpha on the host response to bacterial infection.

  1988cited by this paper
• T helper cell subsets require the expression of distinct costimulatory signals by antigen-presenting cells.

  1988cited by this paper
• Synergy of interleukin 1 and granulocyte colony-stimulating factor: in vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice.

  1987cited by this paper
• Conformation, stability, and folding of interleukin 1 beta.

  1987cited by this paper
• Muteins of human interleukin‐1 that show enhanced bioactivities

  1987cited by this paper
• Interleukin 1 regulates hematopoietic activity, a role previously ascribed to hemopoietin 1.

  1987cited by this paper
• Determination of the minimum polypeptide lengths of the functionally active sites of human interleukins 1 alpha and 1 beta.

  1987cited by this paper
• Enhanced resistance of mice to bacterial infection induced by recombinant human interleukin-1a

  1987cited by this paper
• A 1H-NMR study of human interleukin-1 beta. Sequence-specific assignment of aromatic residues using site-directed mutant proteins.

  1986cited by this paper
• Interleukin 1 alpha and interleukin 1 beta bind to the same receptor on T cells.

  1986cited by this paper
• The cell surface receptors for interleukin-1 alpha and interleukin-1 beta are identical.

  1986cited by this paper
• A 1H‐NMR study of human interleukin‐1β

  1986cited by this paper
• Similarity between the interleukin 1 receptors on a murine T-lymphoma cell line and on a murine fibroblast cell line.

  1986cited by this paper
• Interleukin 1 is a radioprotector.

  1986cited by this paper
• Stimulation of B cell growth and differentiation by murine recombinant interleukin 1.

  1986cited by this paper
• The cell surface receptors for interleukin-1α and interleukin-1β are identical

  1986cited by this paper
• Recombinant human interleukin 1 alpha: purification and biological characterization.

  1986cited by this paper
• Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs

  1985cited by this paper
• Biochemical Characterization of Interleukin 1 From a Human Monocytic Cell Line

  1985cited by this paper
• Interleukin 1 can act as a B-cell growth and differentiation factor.

  1985cited by this paper
• Nucleotide sequence of human monocyte interleukin 1 precursor cDNA.

  1984cited by this paper
• Interleukin-1.

  1984cited by this paper
• Stimulation by human interleukin 1 of cartilage breakdown and production of collagenase and proteoglycanase by human chondrocytes but not by human osteoblasts in vitro.

  1984cited by this paper
• Both a monoclonal antibody and antisera specific for determinants unique to individual cloned helper T cell lines can substitute for antigen and antigen-presenting cells in the activation of T cells

  1983cited by this paper
• Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1).

  1981cited by this paper
• A gas-liquid solid phase peptide and protein sequenator.

  1981cited by this paper
• Purification of a factor from human blood monocyte‐macrophages which stimulates the production of collagenase and prostaglandin E2 by cells cultured from rheumatoid synovial tissues

  1981cited by this paper
• Studies on the purification and structure-functional relationships of murine lymphocyte activating factor (Interleukin 1).

  1980cited by this paper
• Further studies on the reactions of phenylglyoxal and related reagents with proteins.

  1977cited by this paper
• The reaction of phenylglyoxal with arginine residues in proteins.

  1968cited by this paper

• MCC950, a NLRP3 inhibitor, ameliorates lipopolysaccharide-induced lung inflammation in mice.

  2020cites this paper
• Interleukin-1α.

  2013cites this paper
• Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation

  2008cites this paper
• Interleukin-10 inhibits cytokine-mediated synergistic release of interleukin-6 in astrocytoma cells

  2008cites this paper
• IL-1beta epitope mapping using site-directed mutagenesis and hydrogen-deuterium exchange mass spectrometry analysis.

  2005cites this paper
• The interleuldn-1 family: 10 years of discovery’

  2004cites this paper
• INTERLEUKIN-1 UND DIE SERTOLI-ZELLE

  2001cites this paper
• The interleukin-1 family.

  1999cites this paper
• Arg-27, Arg-127 and Arg-155 in the beta-trefoil protein barley alpha-amylase/subtilisin inhibitor are interface residues in the complex with barley alpha-amylase 2.

  1995cites this paper
• Structural and functional characterization of the human formyl peptide receptor ligand-binding region

  1994cites this paper
• Differential sensitivity to Arg side chain modification of IL-1β binding to type I and type II receptors

  1994cites this paper
• Structure-function analysis of human IL-1 alpha: identification of residues required for binding to the human type I IL-1 receptor.

  1993cites this paper